| Programmed Death Receptor 1 | PD-1 |
| Programmed Death-Ligand 1 | PD-L1 |
| Cytotoxic T-lymphocyte-associated protein 4 | CTLA-4 |
| Checkpoint Inhibition | CPI |
| Tumor Microenvironment | TME |
| Alanine Aminotransferase | ALT |
| Aspartate Aminotransferase | AST |
| Treatment-Related Adverse Events | TRAEs |
| Immune-Related Adverse Events | iRAEs |
| Reactive Oxygen Species | ROS |
| Granulocyte–Macrophage Colony Stimulating Factor | GMCSF |
| Acute Myeloid Leukemia | AML |
| Adeno-Associated Virus | AAV |
| Retroviral Replication Vectors | RRV |
| Hematopoietic Stem Cells | HSCs |
| DNA-encoded Monoclonal Antibodies | DMAbs |